moxonidine

Moxonidine is a new-generation centrally acting antihypertensive drug, which is approved for the treatment of mild to moderate essential hypertension. moxonidine has been shown to present blood pressure-independent beneficial effects on insulin resistance syndrome. Reference standards of Moxonidine API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Moxonidine - Impurity B
    [catalogue_number] => PA 13 56020
    [category_ids] => ,79,80,71,78,70,82,
    [chemical_name] => 
    [weight] => 237.26
    [form] => C10H15N5O2
    [cas] => 75439-01-9
    [pslug] => 75439-01-9-moxonidine-impurity-b-pa1356020
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)

Moxonidine - Impurity B

Catalogue No.:PA 13 56020
CAS :
75439-01-9
Molecular Formula : C₁₀H₁₅N₅O₂
Molecular Weight : 237.26

Enquire

Details

stdClass Object
(
    [pname] => Moxonidine - Impurity C
    [catalogue_number] => PA 13 56030
    [category_ids] => ,79,80,71,78,70,82,
    [chemical_name] => 
    [weight] => 223.23
    [form] => C9H13N5O2
    [cas] => 352457-34-2
    [pslug] => 352457-34-2-moxonidine-impurity-c-pa1356030
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)